Head of AI — Yuwell-POCTech
14小时前
Shanghai, 中国
鱼跃
全职
通过电子邮件或 Google 免费
保存此职位并让您的搜索井井有条
创建一个免费帐户来保存职位、创建警报并从仪表板返回此列表。
通过电子邮件或 Google 免费
Job Title
Head of AI — Yuwell-POCTech (Diabetes Care & Metabolic Health)
Reports to: Chairman / General Manager, Yuwell-POCTech
· Direct reports: AI algorithm, AI engineering (LLM/Agent), AI data & evaluation, AI safety leads
·
Location:
Nanjing and/or Shanghai, China (full-time in China, or China-based hybrid — negotiable) About Yuwell-POCTech Yuwell-POCTech is the subsidiary that owns Yuwell's fast-growing diabetes & metabolic care business. Its Anytime (安耐糖) portfolio of CGM (continuous glucose monitoring) systems — including the world's first 16-day, no-calibration CGM with a MARD of 8.58% — is cleared as a NMPA Class III device (2025) and certified under EU MDR Class IIb (January 2026, Anytime 4 & 5). The business also spans BGM/POCT devices, the 安耐糖 consumer app (a top-ranked medical app in China), integrated hospital glucose-management platforms, and next-generation closed-loop insulin therapy. China has ~148 million diabetics with fewer than half diagnosed, plus a national "Weight Management" health campaign and rapidly rising CGM adoption (category GMV in major e-commerce channels grew >90% YoY). This is simultaneously one of the largest and most under-served chronic-care markets in the world — and AI is the core of our answer to it. The Opportunity We are recruiting a Head of AI to build and lead Yuwell-POCTech's AI organization. You will own the AI roadmap that connects our sensors, wearables, apps and services: glucose-accuracy and trend-prediction algorithms, metabolic modeling, LLM-powered health agents and medical knowledge assistants, closed-loop control for automated insulin delivery, and AI features shipped into regulated products across China, Europe and other global markets. You will report to the top of the business, with direct influence on strategy, product and investment — and the scale of a listed group behind you. What You Will Lead Define the AI strategy and product-algorithm roadmap for the diabetes & metabolic care business — CGM signal & accuracy algorithms, hypoglycemia/hyperglycemia prediction and alerting, metabolic & glucose-digestion modeling, LLM/Agent-powered AI health-assistant experiences in the 安耐糖 app and device ecosystem, multi-analyte sensing (uric acid, lactate), and hybrid closed-loop insulin pump control — aligned with Yuwell's 'Globalization
· Intelligence
· Wearables' strategy. Build, recruit and lead a best-in-class AI team across the full stack: LLM post-training & alignment (SFT/DPO/RL), RAG & Agent orchestration, time-series/physiological-signal algorithms, control & modeling, AI data engineering, evaluation and AI safety — talent sourced in China and globally. Own delivery of AI features in medical-device software: algorithm design documentation, verification & validation, clinical study design and data analysis supporting NMPA, EU MDR and future FDA submissions; quality and software lifecycle discipline (ISO 13485, IEC 62304, IEC 62366 usability). Turn AI into measurable clinical and business outcomes: glycemic Time-in-Range and alert performance for patients; engagement, retention, and app-to-service conversion for the business; efficiency gains for hospital glucose-management programs. Establish compliant data infrastructure: device + app + clinical data pipelines and governance enabling continuous model improvement, synthetic data and on-device/edge deployment, under China PIPL, GDPR and other applicable privacy regimes. Lead AI partnerships and ecosystem: top-affiliated hospitals and academia (endocrinology), professional societies (CDS, CATTD), medical large-model and platform collaborations (e.g., JD Health's medical LLM, Ant's health AI), plus developer/open-agent platform initiatives. Represent Yuwell-POCTech's AI capabilities externally: conferences, publications, scientific advisory boards, and hiring brand-building in the global AI + health community. Who We Are Looking For We deliberately accept two backgrounds — as long as the experience is in AI applied to medicine or health: (Track A) a deep technical/scientific leader; or (Track B) a product / commercialization leader of AI-powered health products. You do not need to fit both, but you must be credible and respected by whichever team you lead. Must-haves (both tracks) 8+ years of experience building AI/data-science-driven products or research in healthcare, medical devices, digital therapeutics, health platforms or life sciences, with 4+ years leading teams (managers of managers preferred). A proven record shipping AI that real users or clinicians rely on — not pilots or demos only: named products, measurable impact, scale reached. Fluent in English as a working language (Chinese working ability is a plus, not required for international candidates). Willing to live and work in China (Nanjing/Shanghai; full-time or China-based hybrid). Experience working with or in Chinese R&D and product organizations is a strong plus. Entrepreneurial operator: comfortable building an organization from the middle out, recruiting senior talent, and holding P&L-adjacent accountability alongside product and commercial teams. Track A — Technical / Scientific background Advanced degree (MS/PhD) in CS, EE/BioE, Biomedical Engineering, Statistics, or related field. Hands-on depth across one or more of: LLM post-training & alignment (SFT/DPO/RLHF), RAG & tool-using Agents, time-series / physiological signal modeling, control algorithms (e.g., MPC for closed-loop insulin delivery), distillation/on-device deployment, evaluation & red-teaming of clinical AI. Understanding of medical-device software and clinical data realities (sensor noise, calibration, labeling, clinical validation); familiarity with SaMD regulatory pathways is a plus. Track B — Product / Commercialization background Led 0→1→scale of AI-driven health products or services: chronic-care apps and platforms, CGM/ecosystem software, digital therapeutics, AI health assistants, or payers/services businesses leveraging AI. Able to define AI product strategy, roadmap and pricing/GTM; fluent in translating model capabilities and limits into user value, clinical value and revenue. Experience managing cross-functional teams (product, design, growth, medical affairs, regulatory interfaces) and data-informed iteration discipline; enough technical fluency to challenge and direct algorithm teams. Nice to have Diabetes/endocrinology domain exposure; CGM, insulin pump or automated insulin delivery background. Experience with hospital/health-system deployments, reimbursement or OTC consumer channels in China or the EU/US. Publications, patents, open-source, or recognized talks in AI + health. 职位名称 AI 团队负责人(Head of AI)—— 鱼跃凯立特
· 糖尿病护理与代谢健康管理方向 汇报对象:鱼跃凯立特董事长/总经理(待确认)
· 直辖团队:AI 算法、AI 工程(大模型/智能体)、AI 数据与评测、AI 安全等负责人
· 工作地点:中国南京和/或上海(全职在华,或以中国为主的混合办公,比例可议) 公司与业务背景 鱼跃凯立特(江苏鱼跃凯立特生物科技有限公司)是鱼跃集团旗下血糖管理业务的核心子公司,2021 年通过并购进入 CGM(持续葡萄糖监测)赛道。Anytime“安耐糖”系列产品包括全球首款可持续监测 16 天、免校准、MARD 值 8.58% 的 CGM 产品,2025 年 4 月获 NMPA 三类医疗器械注册证,2026 年 1 月 Anytime 4/5 系列获得欧盟 MDR IIb 类 CE 认证。业务同时覆盖指尖血血糖仪(BGM/POCT)、“鱼跃安耐糖”App(App Store 医疗类同类下载榜首)、院内一体化血糖管理与区域远程慢病管理平台,以及下一代胰岛素泵混合闭环(人工胰腺)等方向。 中国成人糖尿病患者约 1.48 亿、近半数未确诊,叠加 2.74 亿糖尿病前期人群与“体重管理年”等国家政策,CGM 品类在主流电商渠道年增速超 90%——这是全球体量最大、数字化空间最大的慢病管理市场之一,而 AI 是我们回答这一市场问题的核心方式。 这个职位要做什么 我们正在寻找一位 AI 团队负责人,组建并领导鱼跃凯立特的 AI 组织,对“传感器—算法—大模型—应用—服务”全链路 AI 能力负责:让 CGM 更准、更会预测,让安耐糖 App 成为真正的 AI 健康助手,让闭环治疗更安全自动化,并把 AI 能力以合规方式带入中国和全球市场的注册产品中。该职位直接向业务一号位汇报,深度参与战略、产品与投资决策,背靠上市公司的资源与数据规模。 核心职责 制定糖尿病与代谢健康业务的 AI 战略和产品-算法路线图:CGM 信号与精度算法、高/低血糖趋势预测与预警、代谢与血糖-饮食建模、基于大模型/智能体的安耐糖 App 及硬件生态 AI 体验、多指标传感(尿酸、乳酸)、胰岛素泵混合闭环控制算法等,对齐集团“全球化、数智化、穿戴化”战略。 组建并领导全栈 AI 团队:大模型后训练与对齐(SFT/DPO/RL)、RAG 与智能体编排、时序/生理信号算法、控制与建模、AI 数据工程、评测体系与 AI 安全,面向海内外招聘并培养骨干。 对医疗器械软件中的 AI 交付负责:算法设计文档、验证与确认、支持 NMPA / EU MDR / 未来 FDA 申报的临床研究与数据分析,落实 ISO 13485、IEC 62304、IEC 62366 等质量与软件生命周期要求。 对可度量的临床与业务结果负责:患者血糖目标范围内时间(TIR)与预警表现、App 活跃/留存与“设备—服务”转化、院内血糖管理项目效率等业务指标。 建设合规的数据基础设施:设备+App+临床数据的采集、治理与持续学习闭环,掌握合成数据与端侧/轻量化部署,满足中国 PIPL、GDPR 等隐私要求。 主导 AI 生态合作:顶级三甲医院内分泌学科与科研院所、学术组织(CDS、CATTD)、医疗大模型与健康平台合作(如京东健康“京医千询”、蚂蚁健康 AI 等),推进开放平台/AI 智能体开发者生态。 对外代表公司 AI 能力:行业大会演讲、论文与专利、科学顾问委员会,以及在海外 AI+医疗人才圈建立招聘品牌。 任职要求 我们开放两类背景——技术/科研出身,或产品/商业化出身,前提是长期从事 AI + 医学或健康方向。不要求两类能力兼备,但必须能让所领导的团队信服。 必备条件(两类背景均适用) 8 年以上 AI/数据驱动型医疗、医疗器械、数字疗法、健康平台或生命科学相关产品与研发经验,其中 4 年以上团队负责人经验(有“负责人的负责人”层级管理经历者优先)。 有真正上线并被用户或临床实际使用的 AI 产品记录(可具名的产品、可量化的效果与规模),而非仅停留在 PoC/演示。 英语可作为工作语言;国际候选人不强制中文,能用中文工作者优先。 愿意来中国工作(南京/上海,全职或“以中国为主”的混合办公均可);有在中国研发/产品组织工作或协作的经验者优先。 创业者心态:能在业务高速成长期从 0 到 1 搭组织、招揽高端人才,并与产品、医学、注册、商业化团队共担经营结果。 路径 A —— 技术 / 科研背景 计算机科学、电子/生物医学工程、统计等相关专业硕士/博士。 在以下一个或多个方向有深入动手与带队经验:大模型后训练与对齐(SFT/DPO/RLHF)、RAG 与工具调用智能体、时序/生理信号建模、闭环控制算法(如胰岛素泵 MPC)、模型蒸馏与端侧部署、临床 AI 评测与红队测试。 理解医疗器械软件与临床数据的现实约束(传感器噪声、校准、标注、临床验证),熟悉 SaMD 注册路径者加分。 路径 B —— 产品 / 商业化背景 主导过 AI 驱动健康产品/服务的 0→1→规模化:慢病管理平台、CGM 生态软件、数字疗法、AI 健康助手,或以 AI 驱动的服务/付费业务。 能定义 AI 产品战略、路线图与定价/GTM,善于把模型能力边界翻译成用户价值、临床价值与收入。 跨职能团队管理经验(产品、设计、增长、医学事务、注册接口),具备足够技术判断力,能对算法团队提出挑战并给予方向。 加分项 糖尿病/内分泌领域经验;CGM、胰岛素泵或自动胰岛素输注(AID)背景。 医院/医保体系落地、支付与准入,或中国及欧美 OTC 消费渠道经验。 AI+健康领域的论文、专利、开源项目或行业演讲影响力。
· Direct reports: AI algorithm, AI engineering (LLM/Agent), AI data & evaluation, AI safety leads
·
Location:
Nanjing and/or Shanghai, China (full-time in China, or China-based hybrid — negotiable) About Yuwell-POCTech Yuwell-POCTech is the subsidiary that owns Yuwell's fast-growing diabetes & metabolic care business. Its Anytime (安耐糖) portfolio of CGM (continuous glucose monitoring) systems — including the world's first 16-day, no-calibration CGM with a MARD of 8.58% — is cleared as a NMPA Class III device (2025) and certified under EU MDR Class IIb (January 2026, Anytime 4 & 5). The business also spans BGM/POCT devices, the 安耐糖 consumer app (a top-ranked medical app in China), integrated hospital glucose-management platforms, and next-generation closed-loop insulin therapy. China has ~148 million diabetics with fewer than half diagnosed, plus a national "Weight Management" health campaign and rapidly rising CGM adoption (category GMV in major e-commerce channels grew >90% YoY). This is simultaneously one of the largest and most under-served chronic-care markets in the world — and AI is the core of our answer to it. The Opportunity We are recruiting a Head of AI to build and lead Yuwell-POCTech's AI organization. You will own the AI roadmap that connects our sensors, wearables, apps and services: glucose-accuracy and trend-prediction algorithms, metabolic modeling, LLM-powered health agents and medical knowledge assistants, closed-loop control for automated insulin delivery, and AI features shipped into regulated products across China, Europe and other global markets. You will report to the top of the business, with direct influence on strategy, product and investment — and the scale of a listed group behind you. What You Will Lead Define the AI strategy and product-algorithm roadmap for the diabetes & metabolic care business — CGM signal & accuracy algorithms, hypoglycemia/hyperglycemia prediction and alerting, metabolic & glucose-digestion modeling, LLM/Agent-powered AI health-assistant experiences in the 安耐糖 app and device ecosystem, multi-analyte sensing (uric acid, lactate), and hybrid closed-loop insulin pump control — aligned with Yuwell's 'Globalization
· Intelligence
· Wearables' strategy. Build, recruit and lead a best-in-class AI team across the full stack: LLM post-training & alignment (SFT/DPO/RL), RAG & Agent orchestration, time-series/physiological-signal algorithms, control & modeling, AI data engineering, evaluation and AI safety — talent sourced in China and globally. Own delivery of AI features in medical-device software: algorithm design documentation, verification & validation, clinical study design and data analysis supporting NMPA, EU MDR and future FDA submissions; quality and software lifecycle discipline (ISO 13485, IEC 62304, IEC 62366 usability). Turn AI into measurable clinical and business outcomes: glycemic Time-in-Range and alert performance for patients; engagement, retention, and app-to-service conversion for the business; efficiency gains for hospital glucose-management programs. Establish compliant data infrastructure: device + app + clinical data pipelines and governance enabling continuous model improvement, synthetic data and on-device/edge deployment, under China PIPL, GDPR and other applicable privacy regimes. Lead AI partnerships and ecosystem: top-affiliated hospitals and academia (endocrinology), professional societies (CDS, CATTD), medical large-model and platform collaborations (e.g., JD Health's medical LLM, Ant's health AI), plus developer/open-agent platform initiatives. Represent Yuwell-POCTech's AI capabilities externally: conferences, publications, scientific advisory boards, and hiring brand-building in the global AI + health community. Who We Are Looking For We deliberately accept two backgrounds — as long as the experience is in AI applied to medicine or health: (Track A) a deep technical/scientific leader; or (Track B) a product / commercialization leader of AI-powered health products. You do not need to fit both, but you must be credible and respected by whichever team you lead. Must-haves (both tracks) 8+ years of experience building AI/data-science-driven products or research in healthcare, medical devices, digital therapeutics, health platforms or life sciences, with 4+ years leading teams (managers of managers preferred). A proven record shipping AI that real users or clinicians rely on — not pilots or demos only: named products, measurable impact, scale reached. Fluent in English as a working language (Chinese working ability is a plus, not required for international candidates). Willing to live and work in China (Nanjing/Shanghai; full-time or China-based hybrid). Experience working with or in Chinese R&D and product organizations is a strong plus. Entrepreneurial operator: comfortable building an organization from the middle out, recruiting senior talent, and holding P&L-adjacent accountability alongside product and commercial teams. Track A — Technical / Scientific background Advanced degree (MS/PhD) in CS, EE/BioE, Biomedical Engineering, Statistics, or related field. Hands-on depth across one or more of: LLM post-training & alignment (SFT/DPO/RLHF), RAG & tool-using Agents, time-series / physiological signal modeling, control algorithms (e.g., MPC for closed-loop insulin delivery), distillation/on-device deployment, evaluation & red-teaming of clinical AI. Understanding of medical-device software and clinical data realities (sensor noise, calibration, labeling, clinical validation); familiarity with SaMD regulatory pathways is a plus. Track B — Product / Commercialization background Led 0→1→scale of AI-driven health products or services: chronic-care apps and platforms, CGM/ecosystem software, digital therapeutics, AI health assistants, or payers/services businesses leveraging AI. Able to define AI product strategy, roadmap and pricing/GTM; fluent in translating model capabilities and limits into user value, clinical value and revenue. Experience managing cross-functional teams (product, design, growth, medical affairs, regulatory interfaces) and data-informed iteration discipline; enough technical fluency to challenge and direct algorithm teams. Nice to have Diabetes/endocrinology domain exposure; CGM, insulin pump or automated insulin delivery background. Experience with hospital/health-system deployments, reimbursement or OTC consumer channels in China or the EU/US. Publications, patents, open-source, or recognized talks in AI + health. 职位名称 AI 团队负责人(Head of AI)—— 鱼跃凯立特
· 糖尿病护理与代谢健康管理方向 汇报对象:鱼跃凯立特董事长/总经理(待确认)
· 直辖团队:AI 算法、AI 工程(大模型/智能体)、AI 数据与评测、AI 安全等负责人
· 工作地点:中国南京和/或上海(全职在华,或以中国为主的混合办公,比例可议) 公司与业务背景 鱼跃凯立特(江苏鱼跃凯立特生物科技有限公司)是鱼跃集团旗下血糖管理业务的核心子公司,2021 年通过并购进入 CGM(持续葡萄糖监测)赛道。Anytime“安耐糖”系列产品包括全球首款可持续监测 16 天、免校准、MARD 值 8.58% 的 CGM 产品,2025 年 4 月获 NMPA 三类医疗器械注册证,2026 年 1 月 Anytime 4/5 系列获得欧盟 MDR IIb 类 CE 认证。业务同时覆盖指尖血血糖仪(BGM/POCT)、“鱼跃安耐糖”App(App Store 医疗类同类下载榜首)、院内一体化血糖管理与区域远程慢病管理平台,以及下一代胰岛素泵混合闭环(人工胰腺)等方向。 中国成人糖尿病患者约 1.48 亿、近半数未确诊,叠加 2.74 亿糖尿病前期人群与“体重管理年”等国家政策,CGM 品类在主流电商渠道年增速超 90%——这是全球体量最大、数字化空间最大的慢病管理市场之一,而 AI 是我们回答这一市场问题的核心方式。 这个职位要做什么 我们正在寻找一位 AI 团队负责人,组建并领导鱼跃凯立特的 AI 组织,对“传感器—算法—大模型—应用—服务”全链路 AI 能力负责:让 CGM 更准、更会预测,让安耐糖 App 成为真正的 AI 健康助手,让闭环治疗更安全自动化,并把 AI 能力以合规方式带入中国和全球市场的注册产品中。该职位直接向业务一号位汇报,深度参与战略、产品与投资决策,背靠上市公司的资源与数据规模。 核心职责 制定糖尿病与代谢健康业务的 AI 战略和产品-算法路线图:CGM 信号与精度算法、高/低血糖趋势预测与预警、代谢与血糖-饮食建模、基于大模型/智能体的安耐糖 App 及硬件生态 AI 体验、多指标传感(尿酸、乳酸)、胰岛素泵混合闭环控制算法等,对齐集团“全球化、数智化、穿戴化”战略。 组建并领导全栈 AI 团队:大模型后训练与对齐(SFT/DPO/RL)、RAG 与智能体编排、时序/生理信号算法、控制与建模、AI 数据工程、评测体系与 AI 安全,面向海内外招聘并培养骨干。 对医疗器械软件中的 AI 交付负责:算法设计文档、验证与确认、支持 NMPA / EU MDR / 未来 FDA 申报的临床研究与数据分析,落实 ISO 13485、IEC 62304、IEC 62366 等质量与软件生命周期要求。 对可度量的临床与业务结果负责:患者血糖目标范围内时间(TIR)与预警表现、App 活跃/留存与“设备—服务”转化、院内血糖管理项目效率等业务指标。 建设合规的数据基础设施:设备+App+临床数据的采集、治理与持续学习闭环,掌握合成数据与端侧/轻量化部署,满足中国 PIPL、GDPR 等隐私要求。 主导 AI 生态合作:顶级三甲医院内分泌学科与科研院所、学术组织(CDS、CATTD)、医疗大模型与健康平台合作(如京东健康“京医千询”、蚂蚁健康 AI 等),推进开放平台/AI 智能体开发者生态。 对外代表公司 AI 能力:行业大会演讲、论文与专利、科学顾问委员会,以及在海外 AI+医疗人才圈建立招聘品牌。 任职要求 我们开放两类背景——技术/科研出身,或产品/商业化出身,前提是长期从事 AI + 医学或健康方向。不要求两类能力兼备,但必须能让所领导的团队信服。 必备条件(两类背景均适用) 8 年以上 AI/数据驱动型医疗、医疗器械、数字疗法、健康平台或生命科学相关产品与研发经验,其中 4 年以上团队负责人经验(有“负责人的负责人”层级管理经历者优先)。 有真正上线并被用户或临床实际使用的 AI 产品记录(可具名的产品、可量化的效果与规模),而非仅停留在 PoC/演示。 英语可作为工作语言;国际候选人不强制中文,能用中文工作者优先。 愿意来中国工作(南京/上海,全职或“以中国为主”的混合办公均可);有在中国研发/产品组织工作或协作的经验者优先。 创业者心态:能在业务高速成长期从 0 到 1 搭组织、招揽高端人才,并与产品、医学、注册、商业化团队共担经营结果。 路径 A —— 技术 / 科研背景 计算机科学、电子/生物医学工程、统计等相关专业硕士/博士。 在以下一个或多个方向有深入动手与带队经验:大模型后训练与对齐(SFT/DPO/RLHF)、RAG 与工具调用智能体、时序/生理信号建模、闭环控制算法(如胰岛素泵 MPC)、模型蒸馏与端侧部署、临床 AI 评测与红队测试。 理解医疗器械软件与临床数据的现实约束(传感器噪声、校准、标注、临床验证),熟悉 SaMD 注册路径者加分。 路径 B —— 产品 / 商业化背景 主导过 AI 驱动健康产品/服务的 0→1→规模化:慢病管理平台、CGM 生态软件、数字疗法、AI 健康助手,或以 AI 驱动的服务/付费业务。 能定义 AI 产品战略、路线图与定价/GTM,善于把模型能力边界翻译成用户价值、临床价值与收入。 跨职能团队管理经验(产品、设计、增长、医学事务、注册接口),具备足够技术判断力,能对算法团队提出挑战并给予方向。 加分项 糖尿病/内分泌领域经验;CGM、胰岛素泵或自动胰岛素输注(AID)背景。 医院/医保体系落地、支付与准入,或中国及欧美 OTC 消费渠道经验。 AI+健康领域的论文、专利、开源项目或行业演讲影响力。